The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), is centralizing the interest of the scientific world. In the next months, long-term consequences on the endocrine system may arise following COVID-19. In this article, we hypothesized the effects of SARS-CoV-2 taking into account what learned from the severe acute respiratory syndrome coronavirus (SARS-CoV) that caused SARS in 2003.
Possible long-term endocrine-metabolic complications in COVID-19: Lesson from the SARS model
Laura Maria Mongioì;Federica Barbagallo;Rosita A. Condorelli;Rossella Cannarella;Sandro La Vignera;Aldo E. Calogero
2020-01-01
Abstract
The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), is centralizing the interest of the scientific world. In the next months, long-term consequences on the endocrine system may arise following COVID-19. In this article, we hypothesized the effects of SARS-CoV-2 taking into account what learned from the severe acute respiratory syndrome coronavirus (SARS-CoV) that caused SARS in 2003.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Mongioì_COVID19-Endo_27-4-2020.pdf
accesso aperto
Tipologia:
Documento in Pre-print
Dimensione
211.79 kB
Formato
Adobe PDF
|
211.79 kB | Adobe PDF | Visualizza/Apri |
|
Possible long-term endocrine-metabolic complications in COVID-19.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
323.16 kB
Formato
Adobe PDF
|
323.16 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
